Home » Topics » Regulatory

Regulatory
RSS

FDA approves Daiichi's once-daily Azor for hypertension

Oct. 1, 2007

The EC to authorize Yondelis commercialization for soft tissue carcinoma

Sep. 21, 2007

Cubicin expanded indication approved in Europe

Sep. 5, 2007

Smallpox vaccine ACAM-2000 approved by FDA

Sep. 4, 2007

GlaxoSmithKline receives European authorization for Arixtra in the treatment of ACS

Sep. 4, 2007

FDA approves Anesiva's innovative powder analgesic, Zingo, for use in children

Aug. 21, 2007

First approval for Pfizer's novel HIV treatment

Aug. 8, 2007

Health Canada approves GW and Bayer's Sativex for cancer pain

Aug. 7, 2007

FDA approves Indevus's Sanctura XR for once-daily treatment of OAB

Aug. 7, 2007

Toyama receives marketing approval for Geninax in Japan

Aug. 1, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...